Grants per year
Grants
Active
Prot #R475-OA-1758: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients with Pain due to Osteoarthritis of the Hip or Knee
inVentiv Health Clinical, Regeneron Pharmaceuticals, Inc.
2/21/19 → 2/21/22
Project: Research project
Brain Pathophysiology of Osteoarthritis Pain
Apkarian, A., Griffith, J. W., Kahnt, T., Manning, D. W., Parrish, T. B. & Schnitzer, T. J.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
2/1/19 → 12/31/23
Project: Research project
Prot #TGC-15302/KTG-15302: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy and Effectiveness of TG-C in Subjects with Kellgren and Lawrence Grade 2 or 3 Osteoarthritis of the Knee
Parexel, Kolon TissueGene, Inc.
1/28/19 → 1/28/24
Project: Research project
Prot #CL2-201086-002/GLPG1972-CL-201: Efficacy and safety of 3 doses of S201086/GLPG1972 administered orally once daily in patients with knee osteoarthritis. A 52-week international, multi-regional, multi-center, randomized, double-blind, placebo-controll
Medpace Clinical Research LLC, Galapagos NV
12/4/18 → 12/4/21
Project: Research project
Center for chronic pain and drug abuse
Apkarian, A., Awatramani, R., Drenan, R. M., Graves, S. M., Griffith, J. W., Huang, L., Jovasevic, V., Martina, M., Miller, R. J., Parrish, T. B., Procissi, D., Radulovic, J., Rodes, M. E., Schnitzer, T. J., Surmeier Jr, D. J. & Walega, D. R.
National Institute on Drug Abuse
9/1/18 → 6/30/23
Project: Research project
D-Cycloserine for the Treatment of Chronic, Refractory Low Back Pain
Apkarian, A., Griffith, J. W. & Schnitzer, T. J.
U.S. Army Medical Research and Materiel Command
9/30/17 → 9/29/21
Project: Research project
Prot #R475-PN-1523: A Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients with Pain Due to Osteoarthritis of the Knee or Hip
ICON Clinical Research, LLC, Regeneron Pharmaceuticals, Inc.
5/12/16 → 5/12/22
Project: Research project
Prot #R475-PN-1524: A Randomized, Double-blind, Multi-dose, Placebo-controlled Phase 2/3 Study to Evaluate the Efficacy and Safety of Fasinumab in Patients with Moderate to Severe Chronic Low Back Pain
ICON Clinical Research, LLC, Regeneron Pharmaceuticals, Inc.
3/10/16 → 4/15/21
Project: Research project
Finished
Prot #A4091056: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Analgesic Efficacy and Safety of a Dose Titration Regimen for the Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee
INC Research, LLC, Pfizer Inc.
8/2/16 → 8/2/19
Project: Research project
Cortico-striatal plasticity in the transition to chronic pain
Apkarian, A., Griffith, J. W., Martina, M., Parrish, T. B., Procissi, D., Schnitzer, T. J. & Surmeier Jr, D. J.
National Institute of Dental and Craniofacial Research
7/1/16 → 12/31/18
Project: Research project
Brain mechanisms for clinical placebo in chronic pain
Apkarian, A., Cella, D., Gershon, R., Griffith, J. W., Parrish, T. B. & Schnitzer, T. J.
National Center for Complementary and Integrative Health
6/1/16 → 5/31/18
Project: Research project
Prot #42160443PAI3002: Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects with Signs and Symptoms of Osteoarthritis of the Hip or Knee
inVentiv Health Clinical, Janssen Research & Development, LLC
7/22/15 → 7/22/18
Project: Research project